Table 1 Clinical characteristics of the included patients*
From: An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer
Median age: 58 years, range 29-82 | |
|---|---|
Number of patients (%) | |
T | |
1 | 77 (50.3%) |
2 | 76 (49.7%) |
N | |
0 | 96 (62.7%) |
1 | 57 (37.3%) |
Stage | |
I | 61 (39.9%) |
IIa | 51 (33.3%) |
IIb | 41 (26.8%) |
Hormone receptor status | |
ER+/PgR- | 30 (19.6%) |
ER+/PgR+ | 110 (71.9%) |
ER+/PgR unknown | 12 (7.9%) |
ER-/PgR+ | 1 (0.7%) |
Grade | |
1 | 29 (18.9%) |
2 | 64 (41.8%) |
3 | 59 (38.6%) |
Unknown | 1 (0.7%) |
Chemotherapy | |
No chemotherapy | 56 (36.6%) |
CMF | 42 (27.4%) |
Anthracycline-based | 55 (35.9%) |